RecruitingACTRN12612000342819

Role of perinatal factors in formation of neurologic and somatic status at an early age of preterm infants

Endothelial function, intracellular adhesion and apopthosis in perinatal period and their role in formation of neurologic and somatic status at an early age of preterm infants.


Sponsor

Azerbaijan Medical Unversity

Enrollment

200 participants

Start Date

Sep 1, 2011

Study Type

Interventional

Conditions

Summary

The aim of this project is to study the effect of different pathologies of mother-placenta-newborn system on future development and health status of children, the prognosing of developing pathologies and achieving some methods of their prophylaxis.


Eligibility

Sex: Both males and femalesMin Age: 27 WeekssMax Age: 37 Weekss

Plain Language Summary

Simplified for easier understanding

This study is following preterm babies from birth to observe how different complications during pregnancy and delivery affect their health and development as they grow. Researchers will track these babies and their families to understand which early factors predict problems later and how these might be prevented. Babies will undergo developmental assessments and biomarker testing at intervals. You may be eligible if: - Your baby was born premature, between 27 and 37 weeks gestational age - Parents agree to the study assessment requirements, including biomarker analysis and developmental testing You may NOT be eligible if: - Your baby has major congenital anomalies (serious birth defects) Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

We are planning to carry out the scientific research in 4 stages. First stage-maternity hospital (three months long). The first stage of study will be carried out at the maternity hospital. We will

We are planning to carry out the scientific research in 4 stages. First stage-maternity hospital (three months long). The first stage of study will be carried out at the maternity hospital. We will create special investigation history for women of each preterm and low birth weighing delivery. All information about pregnancy (health status, working rejime, family and living environment and ets.) and examination results of women will be fixed in maternal part of history. Physical exam outline and biomarker analysis results of each infant will be included to child part of history. It is planning to detect the level of following biomarkers, which are sensitive to injury of different organs and systems of fetus and specific proteins characterizing changes of pathologic reactions: - markers of endothelial disfunction:endothelin-1, nitric oxide, endothelial nitric oxide synthase; -adhesion molecules: soluble intracellular adhesion molecule -1, soluble vascular cellular adhesion molecule-1; -apoptosis marker: caspasae 9. The level of this markers will be detected in umbilical cord blood and peripheral blood of newborn infants in early neonatal period. Getting the umbilical cord blood is quite safe and nontraumatic for infants, because blood samples will be collected just after birth from placenta side of cord. Peripheral blood samples will not be collected for research, but from other analisis of maternity hospital or neonatal care unit (bilirubin fractions, intrauterine infectious and ets.). Preterm babies will be categorised as less than 30 weeks of gestational age (including 30th week) and more than 30 weeks of gestational age. Intrauterine growth restricted babies will form the subgroup of each group. Second stage – neonatal intensive care unit. This stage will last three months. We will add the diagnosis, examination results, all information about somatic and neural status to investigation history of infant transported from maternity hospital to neonatal intensive care unit. Third stage - polyclinic. This stage will last approximately one year and six months. All infants discharged home from maternity hospital and from neonatal intensive care unit will be controled in polyclinic stage. We will contact directly to polyclinic doctors in appropriate polyclinic and contact to parents of children on telephone conversation. For more attentively control of changes in neurologic and somatic status we are planning personally control of each infant every six week. We will perform this control with our follow up team consisted of pediatrician, neurologist and child psychologist. We will add all information about neuro-somatic status of infants collecting from follow up team and also from polyclinic doctors and parents to investigation history of each infant. Forth stage – statistical analysis of collecting materials and getting reliable results (six months long). We will find the statistical correlations and connects among different pregnancy factors, specific markers of umbilical cord and peripheral blood of infants and neuro-somatic status changes from neonatal till 3 year age of children. Statistical analysis will be realized by non-parametric and parametric methods.


Locations(1)

Baku, Azerbaijan

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12612000342819


Related Trials